Ticker
    ABLI.ST

    Price
    0.15
    Stock movement up
    +0.00 (0.79%)
    Company name
    Abliva AB
    Exchange
    (ST
    ,
    Currency
    SEK
    )
    Sector
    Healthcare >
    Biotechnology
    Market cap
    161.83M
    Ent value
    110.23M
    Price/Sales
    2048.42
    Price/Book
    0.89
    Div yield
    -
    Div growth
    -
    Growth years
    -
    FCF payout
    -
    Trailing P/E
    -
    Forward P/E
    -
    PEG
    -
    EPS growth
    -24.44%
    1 year return
    -33.39%
    3 year return
    -41.11%
    5 year return
    -35.92%
    10 year return
    -40.49%
    Last updated: 2024-04-09

    DIVIDENDS

    ABLI.ST does not pay dividends or no data was received

    VALUATION

    Valuation Ratios

    Valuation Ratios data
    Trailing P/E-
    Price to OCF-
    Price to FCF-
    Price to EBITDA-
    EV to EBITDA-

    Valuation (Sales/Book Value)

    Valuation (Sales/Book Value) data
    Price to Sales2048.42
    Price to Book0.89
    EV to Sales1395.27

    FINANCIALS

    Per share

    Per share data
    Current share count1.06B
    EPS (TTM)-0.16
    FCF per share (TTM)-0.31

    Income statement

    Income statement data
    Revenue (TTM)79.00K
    Gross profit (TTM)0.00
    Operating income (TTM)-102.23M
    Net income (TTM)-104.56M
    EPS (TTM)-0.16
    EPS (1y forward)-

    Margins

    Margins data
    Gross margin (TTM)-
    Operating margin (TTM)-129410.13%
    Profit margin (TTM)-132349.37%

    Balance Sheet

    Please create a free account or log in to access this chart
    Balance Sheet data
    Cash73.44M
    Net receivables94.58M
    Total current assets169.15M
    Goodwill0.00
    Intangible assets20.47M
    Property, plant and equipment0.00
    Total assets203.67M
    Accounts payable15.52M
    Short/Current long term debt0.00
    Total current liabilities21.22M
    Total liabilities21.84M
    Shareholder's equity181.83M
    Net tangible assets161.40M

    Cash flow

    Please create a free account or log in to access this chart
    Cash flow data
    Operating cash flow (TTM)-193.66M
    Capital expenditures (TTM)885.00K
    Free cash flow (TTM)-194.53M
    Dividends paid (TTM)0.00

    Financial returns

    Please create a free account or log in to access this chart
    Financial returns data
    Return on Equity-57.50%
    Return on Assets-51.34%
    Return on Invested Capital-57.50%
    Cash Return on Invested Capital-106.98%

    STOCK INFORMATION

    Stock chart

    Stock price data
    Open0.15
    Daily high0.16
    Daily low0.15
    Daily Volume2.47M
    All-time high80.50
    1y analyst estimate1.00
    Beta1.14
    EPS (TTM)-0.16
    Dividend per share-
    Ex-div date-
    Next earnings date23 May 2024

    Downside potential

    Downside potential data
    ABLI.STS&P500
    Current price drop from All-time high-99.81%-0.85%
    Highest price drop-99.81%-56.47%
    Date of highest drop22 Mar 20249 Mar 2009
    Avg drop from high-75.48%-11.35%
    Avg time to new high84 days13 days
    Max time to new high2437 days1805 days
    COMPANY DETAILS
    ABLI.ST (Abliva AB) company logo
    Marketcap
    161.83M
    Marketcap category
    Small-cap
    Description
    Abliva AB (publ) develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
    Employees
    8
    Website
    https://abliva.com
    Investor relations
    -
    SEC filings
    ABLI.ST SEC filings
    CEO
    Country
    Sweden
    City
    Stock type
    -
    CCC status
    -
    Dividend Frequency
    -
    EVENTS AND PRESENTATIONS
    EventsPresentations
    UNDERSTAND THE BUSINESS
    COMPANY NEWS
    All newsPress releases
    No items found
    Social
    Menu
    Home
    Portfolio Management
    Company Screener
    Green Investment
    Exchanges
    About us
    Contact support
    Language EN | HU | NO | SE | DK | FI | ES | DE | NL | FR | IT | PT | PL | CZ | SK | RO | GR | TR | RU | AF
    Disclaimer
    iO Charts assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
    © 2023 iO Charts All Rights Reserved